SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : corgenix

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: RikRichter5/29/2009 1:33:25 PM
   of 191
 
New Hemorrhagic Virus Named
29 May 2009 15:20:17 GMT
Source: Reuters

JOHANNESBURG, 29 May 2009 (IRIN) - A lethal, newly identified hemorrhagic virus that killed four of the five people it infected in September and October 2008 has been given the working title of "Lujo".

Lujo, a member of the arenavirus family, which currently has 22 known species, was named to reflect its geographic origins: the primary case came from the Zambian capital, Lusaka, and secondary infections occurred in Johannesburg after the patient was transferred to the South African city for treatment.

Dr Lucille Blumberg, deputy director of South Africa's National Institute for Communicable Diseases, told IRIN that humans were most frequently infected with this virus by inhaling dust infected with rodent excreta, or ingestion. The name "Lujo" still has to be approved by "various committees" before it becomes official.

The fifth person to be infected with the Lujo virus - a nurse at Morningside Clinic, Johannesburg - survived after being treated with the antiviral drug, ribavirin, usually prescribed for Lassa fever, a hemorrhagic virus first identified in 1969.

© IRIN. All rights reserved. More humanitarian news and analysis: irinnews.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext